Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter following Coronary Artery Bypass Graft

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10001157

Enrollment

Unknown

Registered

2010-12-12

Start date

2010-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recent-onset atrial fibrillation and atrial flutter following coronary artery bypass grafting

Interventions

amiodarone:amiodarone alone

Ibutilide:Ibutilide alone

combination:amiodarone applied after conversion induced by ibutilide

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Recent-onset atrial fibrillation and atrial flutter following coronary artery bypass grafting; 2. Informed consent signed.

Exclusion criteria

Exclusion criteria: 1. Concomitant use other antiarrhythmic drug; 2. Acute myocardial infarction or unstable angina; 3. Acute congestive heart failure; 4. Ventricular rate=440ms

Design outcomes

Primary

Measure	Time frame
TdP;conversion rate;	—

Secondary

Measure	Time frame
relapse rat;	—

Countries

China

Contacts

Public ContactGuangyu JI

jigy_dor@sohu.com+86 13386276556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026